Joshua Britton is Founder and CEO of Debut located in San Diego. Debut uses cutting-edge
biotechnology to bring novel, high-performing and sustainable ingredients to the cosmetic
industry. Joshua believes that the best way to deliver on the promise of biomanufacturing is
to vertically integrate to product. To that end, Debut is pioneering a new business model in
biology that is driving the beauty industry by discovering, testing, and commercializing
high-performing ingredients and formulations, and incorporating them into valuable beauty
products via BiotechXBeautyLabs™.

At Debut, Joshua leads a rapidly growing multi-disciplinary team of over 100 people
executing an aggressive commercialization strategy. Debut holds over 70 patents in
ingredients and formulations. To date, Joshua has raised $70 million for Debut from leading
funds including BOLD, the venture capital fund of L’Oréal.

Prior to Debut, Joshua was trained as a scientist at the Massachusetts Institute of
Technology (MIT) where he gained a Post-Doc in Chemistry. Joshua also gained a PhD in
Organic Chemistry from University of California, Irvine (UCI), and a master’s degree in
Organic Chemistry from Nottingham University in the UK.

Joshua is an advisor to Cantos Ventures, a venture capital and private equity company that
specializes in near-frontier technology.